28 Jul ITP and Avatrombopag Case
Posted at 13:13h
in
Case Author: Dr Brian Harnett
Case Reviewer: Dr Donald Arnold
Learning Objectives:
At the end of this self-assessment module, participants should be able to:
- Determine appropriate use of thrombopoietin receptor agonists in the setting of immune thrombocytopenia (ITP) and chronic liver disease.
- Determine clinical settings where certain thrombopoietin receptor agonists are more appropriate than others
- Outline relevant pharmacodynamics and pharmacokinetics of
- Describe the initial management of portal vein thrombosis
Scientific Planning Committee
Dr. Pallavi Ganguli – Resident Physician, Hematology
Danyal Ladha – Resident Physician, Hematology
Dr. Joanne Britto – Clinical Fellow, Malignant Hematology (Lymphoproliferative Disorders)
Dr. Yan Xu – Fellow Physician, Hematology/Thrombosis
Dr. Siraj Mithoowani – Clinical Hematologist at St. Joseph’s Healthcare, Hamilton
Dr. Hassan Sibai – Assistant Professor of Medicine, Faculty of Medicine, University of Toronto and Staff Physician,
Division of Medical Hematology & Oncology, Princess Margaret Cancer Centre
Conflict of Interest: None